Search

everythinglearnresearchcommunity

for

Search:↓

Indian dermatologists recommend treating common hair loss with a balanced diet, stress reduction, mild shampoos, and sometimes minoxidil and supplements.

The treatment might help COVID-19 related hair loss, but more research is needed.

Autologous cellular micrografts improve hair density and thickness in the short term for androgenetic alopecia.

Platelet-rich plasma (PRP) is effective in treating various skin conditions and improving hair density, thickness, and patient satisfaction, with lower relapse rates for Alopecia Areata.

The balance of thiol-disulfide in women with hair loss is affected but not damaged.

Microneedling helps with hair loss, especially with 5% minoxidil, but more high-quality research is needed.

The hair lotion reduced hair loss and sped up recovery in women with acute telogen effluvium.

Non-scarring alopecia in females affects emotional well-being and requires accurate diagnosis and personalized treatment.

Post-COVID-19 hair loss is different from androgenetic alopecia and can be identified by lower copper and higher selenium levels.

Combining fractional CO2 laser and PRP is very effective for treating female hair loss.

PRP generally shows better results for hair regrowth than mesotherapy, but more research is needed.

Androgenic alopecia in men is mainly linked to family history, hormonal imbalances, and metabolic issues, but can also be influenced by lifestyle habits, environmental factors, and deficiencies in certain vitamins and microelements like copper.

The evidence for using Low-Level Laser Therapy for hair loss is limited and more thorough research is needed.

Moderately high prolactin levels do not cause hair loss in women.

Hair sheds gradually from the follicle, with readiness to shed indicated by less attachment material.

Female pattern hair loss treatments vary in effectiveness and may have side effects.

Platelet-rich plasma (PRP) shows promise in skin and hair treatments but results vary with preparation methods.

Photoepilation significantly reduces hair, and phototrichograms can objectively measure its effectiveness.

Scalp biopsy and digital phototrichogram help diagnose and manage different types of diffuse hair loss.

Finasteride 1.25 mg showed small improvements in hair density and thickness for female pattern hair loss, but more research is needed.

The document concludes that objective methods are important for diagnosing different types of alopecia and monitoring treatment, and standardizing these techniques is necessary.

HDMHG0401-10 treatment significantly improved hair count and was better than a placebo in reducing hair loss in men with hereditary hair loss, with no major side effects.

COVID-19 may be linked to hair loss called Telogen Effluvium, affecting quality of life and self-esteem.

COVID-19 can cause a type of hair loss that usually starts 3-6 months after the illness, and treatment includes stress reduction and hair care products like Minoxidil.

RV3466F lotion significantly reduces hair loss and improves acute telogen effluvium.

Aging significantly affects the hair and scalp of nonbalding Caucasian women, with changes that differ from male pattern baldness.

The combination of millet seed extract, L-cystine, and calcium pantothenate significantly improved hair growth in women with female pattern hair loss.

Autologous cell-based therapy using dermal sheath cup cells may help treat pattern hair loss, especially in women.

Taking finasteride daily can effectively and safely increase hair density and thickness for women with hair loss.